JP2021105034A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021105034A5 JP2021105034A5 JP2021063301A JP2021063301A JP2021105034A5 JP 2021105034 A5 JP2021105034 A5 JP 2021105034A5 JP 2021063301 A JP2021063301 A JP 2021063301A JP 2021063301 A JP2021063301 A JP 2021063301A JP 2021105034 A5 JP2021105034 A5 JP 2021105034A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- antibody
- lam
- chain variable
- variable region
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023031004A JP2023075196A (ja) | 2016-02-10 | 2023-03-01 | 結核菌（Ｍｙｃｏｂａｃｔｅｒｉｕｍ Ｔｕｂｅｒｃｕｌｏｓｉｓ）感染の診断および治療のための新規な抗－ＬＡＭおよび抗－ＰＩＭ６／ＬＡＭモノクローナル抗体 |
| JP2024137825A JP7813481B2 (ja) | 2016-02-10 | 2024-08-19 | 結核菌（Ｍｙｃｏｂａｃｔｅｒｉｕｍ Ｔｕｂｅｒｃｕｌｏｓｉｓ）感染の診断および治療のための新規な抗－ＬＡＭおよび抗－ＰＩＭ６／ＬＡＭモノクローナル抗体 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662293406P | 2016-02-10 | 2016-02-10 | |
| US62/293,406 | 2016-02-10 | ||
| JP2018541386A JP2019506412A (ja) | 2016-02-10 | 2017-02-01 | 結核菌（Ｍｙｃｏｂａｃｔｅｒｉｕｍ Ｔｕｂｅｒｃｕｌｏｓｉｓ）感染の診断および治療のための新規な抗−ＬＡＭおよび抗−ＰＩＭ６／ＬＡＭモノクローナル抗体 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018541386A Division JP2019506412A (ja) | 2016-02-10 | 2017-02-01 | 結核菌（Ｍｙｃｏｂａｃｔｅｒｉｕｍ Ｔｕｂｅｒｃｕｌｏｓｉｓ）感染の診断および治療のための新規な抗−ＬＡＭおよび抗−ＰＩＭ６／ＬＡＭモノクローナル抗体 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023031004A Division JP2023075196A (ja) | 2016-02-10 | 2023-03-01 | 結核菌（Ｍｙｃｏｂａｃｔｅｒｉｕｍ Ｔｕｂｅｒｃｕｌｏｓｉｓ）感染の診断および治療のための新規な抗－ＬＡＭおよび抗－ＰＩＭ６／ＬＡＭモノクローナル抗体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021105034A JP2021105034A (ja) | 2021-07-26 |
| JP2021105034A5 true JP2021105034A5 (https=) | 2022-01-11 |
| JP7316685B2 JP7316685B2 (ja) | 2023-07-28 |
Family
ID=59563993
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018541386A Pending JP2019506412A (ja) | 2016-02-10 | 2017-02-01 | 結核菌（Ｍｙｃｏｂａｃｔｅｒｉｕｍ Ｔｕｂｅｒｃｕｌｏｓｉｓ）感染の診断および治療のための新規な抗−ＬＡＭおよび抗−ＰＩＭ６／ＬＡＭモノクローナル抗体 |
| JP2021063301A Active JP7316685B2 (ja) | 2016-02-10 | 2021-04-02 | 結核菌（Ｍｙｃｏｂａｃｔｅｒｉｕｍ Ｔｕｂｅｒｃｕｌｏｓｉｓ）感染の診断および治療のための新規な抗－ＬＡＭおよび抗－ＰＩＭ６／ＬＡＭモノクローナル抗体 |
| JP2023031004A Pending JP2023075196A (ja) | 2016-02-10 | 2023-03-01 | 結核菌（Ｍｙｃｏｂａｃｔｅｒｉｕｍ Ｔｕｂｅｒｃｕｌｏｓｉｓ）感染の診断および治療のための新規な抗－ＬＡＭおよび抗－ＰＩＭ６／ＬＡＭモノクローナル抗体 |
| JP2024137825A Active JP7813481B2 (ja) | 2016-02-10 | 2024-08-19 | 結核菌（Ｍｙｃｏｂａｃｔｅｒｉｕｍ Ｔｕｂｅｒｃｕｌｏｓｉｓ）感染の診断および治療のための新規な抗－ＬＡＭおよび抗－ＰＩＭ６／ＬＡＭモノクローナル抗体 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018541386A Pending JP2019506412A (ja) | 2016-02-10 | 2017-02-01 | 結核菌（Ｍｙｃｏｂａｃｔｅｒｉｕｍ Ｔｕｂｅｒｃｕｌｏｓｉｓ）感染の診断および治療のための新規な抗−ＬＡＭおよび抗−ＰＩＭ６／ＬＡＭモノクローナル抗体 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023031004A Pending JP2023075196A (ja) | 2016-02-10 | 2023-03-01 | 結核菌（Ｍｙｃｏｂａｃｔｅｒｉｕｍ Ｔｕｂｅｒｃｕｌｏｓｉｓ）感染の診断および治療のための新規な抗－ＬＡＭおよび抗－ＰＩＭ６／ＬＡＭモノクローナル抗体 |
| JP2024137825A Active JP7813481B2 (ja) | 2016-02-10 | 2024-08-19 | 結核菌（Ｍｙｃｏｂａｃｔｅｒｉｕｍ Ｔｕｂｅｒｃｕｌｏｓｉｓ）感染の診断および治療のための新規な抗－ＬＡＭおよび抗－ＰＩＭ６／ＬＡＭモノクローナル抗体 |
Country Status (10)
| Country | Link |
|---|---|
| US (4) | US10729771B2 (https=) |
| EP (2) | EP3414573B1 (https=) |
| JP (4) | JP2019506412A (https=) |
| CN (2) | CN110092830B (https=) |
| AU (2) | AU2017218415B2 (https=) |
| CA (1) | CA3013904C (https=) |
| ES (1) | ES2970828T3 (https=) |
| RU (1) | RU2732502C2 (https=) |
| WO (1) | WO2017139153A1 (https=) |
| ZA (3) | ZA201805990B (https=) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10729771B2 (en) | 2016-02-10 | 2020-08-04 | Rutgers, The State University Of New Jersey | Anti-LAM and anti-PIM6/LAM monoclonal antibodies for diagnosis and treatment of Mycobacterium tuberculosis infections |
| US10830760B2 (en) * | 2017-12-20 | 2020-11-10 | General Electric Company | Device for rapid detection of tuberculosis-lipoarabinomannan (TB-LAM) with enhanced sensitivity |
| EP3775904A1 (en) * | 2018-03-29 | 2021-02-17 | Foundation of Innovative New Diagnostics | Antibody or antibody combination and method using same for detection of an antigen related to mycobacterium in a urine sample of a subject |
| US20210302424A1 (en) | 2018-07-19 | 2021-09-30 | Rutgers, The State University Of New Jersey | Methods for dual detection and differentiation of infection by mycobacterium tuberculosis complex and nontuberculous mycobacteria |
| JP7130045B2 (ja) | 2018-08-31 | 2022-09-02 | 富士フイルム株式会社 | イムノクロマトグラフキットおよび結核菌の検出方法 |
| CN114341639A (zh) | 2019-09-30 | 2022-04-12 | 富士胶片株式会社 | 免疫检查方法及浓缩用夹具 |
| CN114341640B (zh) | 2019-09-30 | 2025-11-28 | 富士胶片株式会社 | 免疫层析法 |
| CN111337665A (zh) * | 2020-01-16 | 2020-06-26 | 卢氏实验室公司 | 一种用于检测肺结核感染的免疫层析试纸条及其制备方法 |
| JP7350100B2 (ja) | 2020-01-31 | 2023-09-25 | 富士フイルム株式会社 | イムノクロマトグラフィー |
| WO2021152966A1 (ja) | 2020-01-31 | 2021-08-05 | 富士フイルム株式会社 | イムノクロマトグラフィー |
| WO2021153127A1 (ja) | 2020-01-31 | 2021-08-05 | 富士フイルム株式会社 | 免疫検査方法 |
| CN111153992A (zh) * | 2020-02-21 | 2020-05-15 | 首都医科大学附属北京胸科医院 | 结核分枝杆菌lam的单克隆抗体及其用途 |
| EP4178610A4 (en) * | 2020-07-07 | 2024-08-28 | The Regents Of The University Of California | METHODS FOR DETECTION OF ANTIGENS FROM DIRECT CLINICAL SAMPLES |
| EP4192429A4 (en) * | 2020-08-05 | 2024-10-09 | The Administrators of The Tulane Educational Fund | METHOD FOR DETECTING TB IN BODY FLUID SAMPLES |
| CN116113826B (zh) | 2020-09-11 | 2026-02-27 | 富士胶片株式会社 | 浓缩器件、被检体液的浓缩方法、被检体液的检查方法、及检查试剂盒 |
| WO2022054510A1 (ja) | 2020-09-11 | 2022-03-17 | 富士フイルム株式会社 | 検体液の濃縮方法、及び、検体液の検査方法 |
| EP4212873B1 (en) | 2020-09-11 | 2026-04-08 | FUJIFILM Corporation | Concentration device, method for concentrating sample solution, method for testing sample solution, and test kit |
| WO2022081716A1 (en) * | 2020-10-13 | 2022-04-21 | Accubit LLC - Biotechnology | Methods of treating iga nephropathy with thiol-containing molecules |
| US20240101650A1 (en) * | 2020-12-15 | 2024-03-28 | Albert Einstein College Of Medicine | High-Affinity Mycobacterium Tuberculosis Capsule-Specific Human Monoclonal Antibody |
| CN113480659B (zh) * | 2021-06-30 | 2022-10-21 | 迪比康(上海)生物科技有限公司 | 人源抗结核分枝杆菌复合群lam单克隆抗体及其制备和应用 |
| CN114984870A (zh) * | 2022-03-15 | 2022-09-02 | 齐欣 | 一种重组蛋白质微球及其制备方法和应用 |
| CN117247450B (zh) * | 2023-10-10 | 2025-02-25 | 广州市雷德生物科技有限公司 | 一种lam抗体及其应用 |
| CN118178640B (zh) * | 2024-03-08 | 2025-11-21 | 中国农业大学 | 含有牛分枝杆菌表面多糖的佐剂及其应用 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3773919A (en) | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
| IE52535B1 (en) | 1981-02-16 | 1987-12-09 | Ici Plc | Continuous release pharmaceutical compositions |
| HUT35524A (en) | 1983-08-02 | 1985-07-29 | Hoechst Ag | Process for preparing pharmaceutical compositions containing regulatory /regulative/ peptides providing for the retarded release of the active substance |
| US4636524A (en) | 1984-12-06 | 1987-01-13 | Biomatrix, Inc. | Cross-linked gels of hyaluronic acid and products containing such gels |
| EP2283821A1 (en) | 1993-11-19 | 2011-02-16 | Alkermes, Inc. | Preparation of biodegradable microparticles containing a biologically active agent |
| US6656508B2 (en) | 1997-04-17 | 2003-12-02 | Amgen Inc. | Sustained-release alginate gels |
| US20010007660A1 (en) * | 1997-06-04 | 2001-07-12 | Aharona Glatman-Freedman | Methods of treating and protecting against tuberculosis using a monoclonal antibody selective for mycobacterium tuberculosis |
| AU1384199A (en) | 1997-11-07 | 1999-05-31 | Chiron Corporation | Method for producing igf-1 sustained-release formulations |
| US6541033B1 (en) | 1998-06-30 | 2003-04-01 | Amgen Inc. | Thermosensitive biodegradable hydrogels for sustained delivery of leptin |
| US6451346B1 (en) | 1998-12-23 | 2002-09-17 | Amgen Inc | Biodegradable pH/thermosensitive hydrogels for sustained delivery of biologically active agents |
| US6953593B2 (en) | 2000-02-01 | 2005-10-11 | Lipoprotein Technologies, Inc. | Sustained-release microencapsulated delivery system |
| AU2002248792B2 (en) | 2001-04-18 | 2006-09-21 | Nostrum Pharmaceuticals Inc. | A novel coating for a sustained release pharmaceutical composition |
| US7063725B2 (en) | 2002-10-21 | 2006-06-20 | Sdgi Holdings, Inc. | Systems and techniques for restoring and maintaining intervertebral anatomy |
| CA2437639C (en) | 2003-08-11 | 2016-07-05 | Valera Pharmaceuticals, Inc. | Long term drug delivery devices with polyurethane based polymers and their manufacture |
| US20050187631A1 (en) | 2004-01-27 | 2005-08-25 | Sdgi Holdings, Inc. | Prosthetic device |
| DE602005026665D1 (de) * | 2004-07-20 | 2011-04-14 | Chemogen Inc | Angereicherter antikörper zur detektion von mikrobakterieller infektion, verfahren zur anwendung und diagnosetest damit |
| CN101216491B (zh) * | 2008-01-08 | 2012-06-06 | 广州益善生物技术有限公司 | 结核分枝杆菌检测液相芯片及其制备方法 |
| EP2242836B1 (en) * | 2008-01-28 | 2015-05-20 | Thomas Jefferson University | Method of making hybrid cells that express useful antibodies |
| JP2012502649A (ja) | 2008-09-19 | 2012-02-02 | メディミューン，エルエルシー | Ｃｄ１０５を対象とする標的結合剤およびその使用 |
| US8673845B2 (en) * | 2009-07-29 | 2014-03-18 | Toagosei Co., Ltd. | Carrier peptide fragment and use thereof |
| SG10201600531TA (en) * | 2011-01-24 | 2016-02-26 | Univ Singapore | Pathogenic mycobacteria-derived mannose-capped lipoarabinomannan antigen binding proteins |
| AU2013205658B2 (en) * | 2012-02-29 | 2015-04-16 | Otsuka Pharmaceutical Co., Ltd. | Anti - Lipoarabinomannan antibody and immunoassay for acid - fast bacillary infection using the antibody |
| JO3462B1 (ar) * | 2012-08-22 | 2020-07-05 | Regeneron Pharma | أجسام مضادة بشرية تجاه gfr?3 وطرق لاستخدامها |
| US10729771B2 (en) | 2016-02-10 | 2020-08-04 | Rutgers, The State University Of New Jersey | Anti-LAM and anti-PIM6/LAM monoclonal antibodies for diagnosis and treatment of Mycobacterium tuberculosis infections |
-
2017
- 2017-02-01 US US16/076,971 patent/US10729771B2/en active Active
- 2017-02-01 EP EP17750586.4A patent/EP3414573B1/en active Active
- 2017-02-01 RU RU2018131622A patent/RU2732502C2/ru active
- 2017-02-01 JP JP2018541386A patent/JP2019506412A/ja active Pending
- 2017-02-01 ES ES17750586T patent/ES2970828T3/es active Active
- 2017-02-01 CN CN201910291444.8A patent/CN110092830B/zh active Active
- 2017-02-01 EP EP23208073.9A patent/EP4299072A3/en active Pending
- 2017-02-01 CA CA3013904A patent/CA3013904C/en active Active
- 2017-02-01 AU AU2017218415A patent/AU2017218415B2/en active Active
- 2017-02-01 CN CN201780017369.5A patent/CN109073649A/zh active Pending
- 2017-02-01 WO PCT/US2017/016058 patent/WO2017139153A1/en not_active Ceased
-
2018
- 2018-09-06 ZA ZA2018/05990A patent/ZA201805990B/en unknown
-
2020
- 2020-06-24 US US16/910,621 patent/US11273220B2/en active Active
-
2021
- 2021-04-02 JP JP2021063301A patent/JP7316685B2/ja active Active
-
2022
- 2022-02-17 US US17/651,523 patent/US11707525B2/en active Active
- 2022-08-12 ZA ZA2022/09045A patent/ZA202209045B/en unknown
-
2023
- 2023-03-01 JP JP2023031004A patent/JP2023075196A/ja active Pending
- 2023-06-15 US US18/335,489 patent/US12303562B2/en active Active
- 2023-08-15 ZA ZA2023/07912A patent/ZA202307912B/en unknown
-
2024
- 2024-08-01 AU AU2024205286A patent/AU2024205286A1/en active Pending
- 2024-08-19 JP JP2024137825A patent/JP7813481B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021105034A5 (https=) | ||
| JP2019506412A5 (https=) | ||
| RU2018131622A (ru) | Новые моноклональные антитела к LAM и PIM6/LAM для диагностики и лечения инфекций, вызванных Mycobacterium tuberculosis | |
| JP2022031635A5 (https=) | ||
| JP2021191763A5 (https=) | ||
| JP2024156657A5 (https=) | ||
| JP2009225799A5 (https=) | ||
| JP2024054410A5 (https=) | ||
| JP2018535650A5 (https=) | ||
| JP2018512138A5 (https=) | ||
| JP2018516853A5 (https=) | ||
| JP2020522261A5 (https=) | ||
| JP2010536384A5 (https=) | ||
| JP2009517057A5 (https=) | ||
| FI3322727T3 (fi) | Humanisoituja tai kimeerisiä CD3-vasta-aineita | |
| RU2011105062A (ru) | Нейтрализующие антитела против вируса гриппа а и их использование | |
| JP2013506428A5 (https=) | ||
| RU2009148597A (ru) | Новые показания к применению при лечении антителами против il-1-бета | |
| RU2009129403A (ru) | Антитела, нейтрализующие цитомегаловирус человека, и их применение | |
| RU2021129189A (ru) | Антитела против фактора свертывания xi | |
| RU2014118462A (ru) | Gp41-нейтрализующие антитела и их применение | |
| RU2015151505A (ru) | Антитела, направленные к белку запрограммированной гибели клетки-1 (pd-1) | |
| JP2016501877A5 (https=) | ||
| JP2021502984A5 (https=) | ||
| JP2014529610A5 (https=) |